
Please try another search
CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as CardieX Limited and changed its name to CONNEQT Health Limited in September 2025. CONNEQT Health Limited was founded in 1994 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Craig R. Cooper | 62 | 2017 | Co-Founder, Group CEO, MD & Executive Director |
Harry Kim | - | 2019 | Special Advisor |
Charlie Taylor | - | 2024 | Independent Non-Executive Director |
Randall King Nelson | 68 | 2015 | Independent Non-Executive Director |
Alberto Avolio | - | - | Member of Medical Advisory Board |
Niall Charles Edgar Cairns | 61 | 2017 | Co-Founder & Executive Chairman |
John Cockcroft | - | 2022 | Member of Medical Advisory Board |
Joseph Raffaele | - | 2025 | Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review